Opioids
The House Energy and Commerce Health Subcommittee this afternoon held the first of three planned hearings to examine the opioid crisis and possible legislative solutions, which reviewed several bills pertaining to the Controlled Substances Act.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,00 health care leaders who belong to our professional membership…
Sens. Rob Portman (R-OH), Sheldon Whitehouse (D-RI), Shelley Moore Capito (R-WV), Amy Klobuchar (D-MN), Dan Sullivan (R-AK), Maggie Hassan (D-NH), Bill Cassidy (R-LA) and Maria Cantwell (D-WA) today introduced the Comprehensive Addiction and Recovery Act 2.0, legislation that would increase funding…
The AHA, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Institute for Safe Medication Practices, and American Society of Clinical Oncology today urged the Drug Enforcement Administration to temporarily adjust the aggregate production quotas for certain…
The undersigned groups respectfully request that the Drug Enforcement Administration (DEA)
adjust aggregate production quotas (APQ) for certain opioids in order to mitigate ongoing drug
shortages.
U.S. deaths from alcohol, drugs and suicide increased by 11% in 2016, to nearly 142,000, according to a report released today by Trust for America’s Health and Well Being Trust.
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating a multistate outbreak of salmonella linked to products reported to contain kratom.
Responding to a request from Senate Finance Committee leaders for policy recommendations to address the opioid epidemic, AHA urged the committee Friday to preserve health insurance coverage through the exchanges and Medicaid.
The ºÚÁÏÕýÄÜÁ¿ Association responds to the Senate Finance Committee’s request for policy recommendations to address the opioid epidemic.
The Substance Abuse and Mental Health Services Administration yesterday issued guidance for health care and addiction professionals using methadone, naltrexone or buprenorphine to treat patients with opioid use disorder.